New immunotherapy combination tolerable, effective in patients with advanced kidney cancer – EurekAlert (press release)
|
New immunotherapy combination tolerable, effective in patients with advanced kidney cancer
EurekAlert (press release) WASHINGTON — Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with … |
